Circulating microRNA signatures in mice exposed to lipoteichoic acid

Journal of Biomedical Science

Volumn 20, Issue 1, 2013, Pages

  Hsieh, Ching Hua ^a   Yang, Johnson Chia Shen ^a   Jeng, Jonathan Chris ^b   Chen, Yi Chun ^a   Lu, Tsu Hsiang ^a   Tzeng, Siou Ling ^a   Wu, Yi Chan ^a   Wu, Chia Jung ^a   Rau, Cheng Shyuan ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Gram negative bacteria; Gram positive bacteria; Lipopolysaccharide; Lipoteichoic acid; Microarray; MicroRNAs; Toll like receptor

Indexed keywords

LIPOTEICHOIC ACID; MICRORNA; MICRORNA 1902; MICRORNA 1904; MICRORNA 451; MICRORNA 668; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG; LIPOPOLYSACCHARIDE; TEICHOIC ACID; TRANSCRIPTOME;

ANIMAL EXPERIMENT; ARTICLE; BACILLUS SUBTILIS; BLOOD SAMPLING; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; LEUKOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS AUREUS; UPREGULATION; ANIMAL; BLOOD; CHEMISTRY; DRUG EFFECT; GENETICS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; ISOLATION AND PURIFICATION; PATHOGENICITY;

BACILLUS SUBTILIS; ENTEROCOCCUS FAECALIS; MUS; NEGIBACTERIA; POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

ANIMALS; BACILLUS SUBTILIS; ENTEROCOCCUS FAECALIS; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; LIPOPOLYSACCHARIDES; MICE; MICRORNAS; STAPHYLOCOCCUS AUREUS; TEICHOIC ACIDS; TRANSCRIPTOME;

EID: 84871732992     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-20-2     Document Type: Article

References (39)

1. The diverse functions of microRNAs in animal development and disease. Kloosterman WP, Plasterk RH, Dev Cell 2006 11 4 441 450 10.1016/j.devcel.2006. 09.009 17011485
2. Small non-coding RNAs in animal development. Stefani G, Slack FJ, Nat Rev Mol Cell Biol 2008 9 3 219 230 10.1038/nrm2347 18270516
3. Regulatory RNAs: future perspectives in diagnosis, prognosis, and individualized therapy. Perron MP, Boissonneault V, Gobeil LA, Ouellet DL, Provost P, Methods Mol Biol 2007 361 311 326 17172720
4. Extracellular microRNA: a new source of biomarkers. Etheridge A, Lee I, Hood L, Galas D, Wang K, Mutat Res 2011 717 1-2 85 90 21402084
5. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, et al. Cell Res 2008 18 10 997 1006 10.1038/cr.2008.282 18766170
6. Circulating microRNAs as stable blood-based markers for cancer detection. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, et al. Proc Natl Acad Sci U S A 2008 105 30 10513 10518 10.1073/pnas.0804549105 18663219
7. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Kosaka N, Iguchi H, Ochiya T, Cancer Sci 2010 101 10 2087 2092 10.1111/j.1349-7006.2010.01650.x 20624164
8. The microRNA spectrum in 12 body fluids. Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, Galas DJ, Wang K, Clin Chem 2010 56 11 1733 1741 10.1373/clinchem.2010.147405 20847327
9. Serum microRNAs are promising novel biomarkers. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, Benjamin H, Kushnir M, Cholakh H, Melamed N, et al. PLoS One 2008 3 9 3148 10.1371/journal.pone.0003148 18773077
10. Circulating miRNAs: promising biomarkers of human cancer. Qu H, Xu W, Huang Y, Yang S, Asian Pac J Cancer Prev 2011 12 5 1117 1125 21875254
11. Multiple organ failure in sepsis: prognosis and role of systemic inflammatory response. Gustot T, Curr Opin Crit Care 2011 17 2 153 159 10.1097/MCC.0b013e328344b446 21346564
12. Microbe-associated molecular patterns in innate immunity: extraction and chemical analysis of gram-negative bacterial lipopolysaccharides. De Castro C, Parrilli M, Holst O, Molinaro A, Methods Enzymol 2010 480 89 115 20816206
13. Gram-positive toxic shock syndromes. Lappin E, Ferguson AJ, Lancet Infect Dis 2009 9 5 281 290 10.1016/S1473-3099(09)70066-0 19393958
14. Whole blood-derived microRNA signatures in mice exposed to lipopolysaccharides. Hsieh CH, Rau CS, Jeng JC, Chen YC, Lu TH, Wu CJ, Wu YC, Tzeng SL, Yang JC, J Biomed Sci 2012 19 69 10.1186/1423-0127-19-69 22849760
15. Profiling microRNAs in lung tissue from pigs infected with Actinobacillus pleuropneumoniae. Podolska A, Anthon C, Bak M, Tommerup N, Skovgaard K, Heegaard PM, Gorodkin J, Cirera S, Fredholm M, BMC Genomics 2012 13 459 1471 2164
16. miR-451 regulates dendritic cell cytokine responses to influenza infection. Rosenberger CM, Podyminogin RL, Navarro G, Zhao GW, Askovich PS, Weiss MJ, Aderem A, J Immunol 2012 189 12 5965 5975 10.4049/jimmunol.1201437 23169590
17. Haemolysis during sample preparation alters microRNA content of plasma. Kirschner MB, Kao SC, Edelman JJ, Armstrong NJ, Vallely MP, van Zandwijk N, Reid G, PLoS One 2011 6 9 1
18. Circulating miRNAs might be promising biomarkers to reflect the dynamic pathological changes in smoking-related interstitial fibrosis. Yuchuan H, Ya D, Jie Z, Jingqiu C, Yanrong L, Dongliang L, Changguo W, Kuoyan M, Guangneng L, Fang X, et al. Toxicol Ind Health 2012 10 10
19. Differential miRNA expression in the mouse jejunum during garlic treatment of Eimeria papillata infections. Al-Quraishy S, Delic D, Sies H, Wunderlich F, Abdel-Baki AA, Dkhil MA, Parasitol Res 2011 109 2 387 394 10.1007/s00436-011-2266-y 21301871
20. Multiple amino acid substitutions involved in enhanced pathogenicity of LPAI H9N2 in mice. Zhang Z, Hu S, Li Z, Wang X, Liu M, Guo Z, Li S, Xiao Y, Bi D, Jin H, Infect Genet Evol 2011 11 7 1790 1797 10.1016/j.meegid.2011.07.025 21896338
21. Method for microRNA isolation from clinical serum samples. Li Y, Kowdley KV, Anal Biochem 2012 11 12 007
22. Identification of suitable reference genes for qPCR analysis of serum microRNA in gastric cancer patients. Song J, Bai Z, Han W, Zhang J, Meng H, Bi J, Ma X, Han S, Zhang Z, Dig Dis Sci 2012 57 4 897 904 10.1007/s10620-011-1981-7 22198701
23. MicroRNAs: the fine-tuners of Toll-like receptor signalling. O'Neill LA, Sheedy FJ, McCoy CE, Nat Rev Immunol 2011 11 3 163 175 10.1038/nri2957 21331081
24. Location, synthesis and function of glycolipids and polyglycerolphosphate lipoteichoic acid in Gram-positive bacteria of the phylum Firmicutes. Reichmann NT, Grundling A, FEMS Microbiol Lett 2011 319 2 97 105 10.1111/j.1574-6968. 2011.02260.x 21388439
25. Lipoteichoic acid and lipids in the membrane of Staphylococcus aureus. Fischer W, Med Microbiol Immunol 1994 183 2 61 76 10.1007/BF00277157 7935161
26. Differential immunostimulatory effects of Gram-positive bacteria due to their lipoteichoic acids. Ryu YH, Baik JE, Yang JS, Kang SS, Im J, Yun CH, Kim DW, Lee K, Chung DK, Ju HR, et al. Int Immunopharmacol 2009 9 1 127 133 10.1016/j.intimp.2008.10.014 19013542
27. Intrinsic nitric oxide-stimulatory activity of lipoteichoic acids from different Gram-positive bacteria. Zidek Z, Farghali H, Kmonickova E, Nitric Oxide 2010 23 4 300 310 10.1016/j.niox.2010.09.001 20850558
28. Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus. Hashimoto M, Tawaratsumida K, Kariya H, Kiyohara A, Suda Y, Krikae F, Kirikae T, Gotz F, J Immunol 2006 177 5 3162 3169 16920954
29. Evidence of immunostimulating lipoprotein existing in the natural lipoteichoic acid fraction. Hashimoto M, Furuyashiki M, Kaseya R, Fukada Y, Akimaru M, Aoyama K, Okuno T, Tamura T, Kirikae T, Kirikae F, et al. Infect Immun 2007 75 4 1926 1932 10.1128/IAI.02083-05 17283098
30. The peptidoglycan recognition proteins (PGRPs). Dziarski R, Gupta D, Genome Biol 2006 7 8 232 10.1186/gb-2006-7-8-232 16930467
31. Toll-like receptors (TLRs) in innate immune defense against Staphylococcus aureus. Pietrocola G, Arciola CR, Rindi S, Di Poto A, Missineo A, Montanaro L, Speziale P, Int J Artif Organs 2011 34 9 799 810 10.5301/ijao.5000030 22094559
32. Membrane sorting of toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. Triantafilou M, Gamper FG, Haston RM, Mouratis MA, Morath S, Hartung T, Triantafilou K, J Biol Chem 2006 281 41 31002 31011 10.1074/jbc.M602794200 16880211
33. Atypical lipoteichoic acids of gram-positive bacteria. Sutcliffe IC, Shaw N, J Bacteriol 1991 173 22 7065 7069 1938910
34. MicroRNAs in body fluids - the mix of hormones and biomarkers. Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA, Nat Rev Clin Oncol 2011 8 8 467 477 10.1038/nrclinonc.2011.76 21647195
35. MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Cortez MA, Calin GA, Expert Opin Biol Ther 2009 9 6 703 711 10.1517/14712590902932889 19426115
36. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT, Nat Cell Biol 2011 13 4 423 433 10.1038/ncb2210 21423178
37. Characterization of extracellular circulating microRNA. Turchinovich A, Weiz L, Langheinz A, Burwinkel B, Nucleic Acids Res 2011 39 16 7223 7233 10.1093/nar/gkr254 21609964
38. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, Mitchell PS, Bennett CF, Pogosova-Agadjanyan EL, Stirewalt DL, et al. Proc Natl Acad Sci U S A 2011 108 12 5003 5008 10.1073/pnas.1019055108 21383194
39. Export of microRNAs and microRNA-protective protein by mammalian cells. Wang K, Zhang S, Weber J, Baxter D, Galas DJ, Nucleic Acids Res 2010 38 20 7248 7259 10.1093/nar/gkq601 20615901